Regulatory Convergence for Healthcare Products in North Africa
February 10 - 11, 2025 | Cairo, Egypt
The U.S. Trade and Development Agency (USTDA) in collaboration with the Corporate Council on Africa (CCA) presents a Workshop Series on Regulatory Convergence for Healthcare Products in Africa.
In this series, we will host four distinct, regionally focused workshops that will set the stage and lead up to a final continent-wide workshop. Each workshop will include a dedicated day for pharmaceutical products and another dedicated day for medical devices. These sessions will convene a select group of key stakeholders, including pharmaceutical and medical device companies, trade associations from both the United States and Africa, as well as regulatory authorities and government agencies from both regions. The primary objective is to foster discussions on the most effective regulatory practices for pharmaceuticals and medical devices, with the overarching goal of promoting harmonization with international standards and achieving convergence in healthcare regulatory systems.
Through this series, we aim to:
- Promote increased collaboration between regulatory authorities and industry.
- Facilitate broader market access for healthcare products while enhancing the quality and availability of pharmaceuticals and medical devices across the continent.
- Improve application and approval timelines/processes.
- Provide a platform for participants to network and exchange ideas, experiences, and best practices for strengthening regulatory systems in Africa.
WHY YOU SHOULD ATTEND:
- Explore and discuss regulatory harmonization efforts in North Africa.
- Learn how technology can improve communication, regulatory process efficiency, transparency and governance.
- Participate in B2B and B2G discussions about what is needed to transition to harmonization
- Discover sustainable financing models for regulatory harmonization.
- Understand the differences between medical devices vs pharma across the value chain.
- See live demonstrations of new medical devices available in the market.